DexCom Inc (DXCM)vsiTonic Holdings Ltd. (ITOC)
DXCM
DexCom Inc
$86.45
+2.09%
HEALTHCARE · Cap: $31.90B
ITOC
iTonic Holdings Ltd.
$0.30
+1.92%
HEALTHCARE · Cap: $7.34M
Smart Verdict
WallStSmart Research — data-driven comparison
DexCom Inc generates 949979% more annual revenue ($4.97B vs $523,030). DXCM leads profitability with a 20.1% profit margin vs 0.0%. DXCM earns a higher WallStSmart Score of 74/100 (B).
DXCM
Strong Buy74
out of 100
Grade: B
ITOC
Avoid33
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 38 in profit
Keeps 20 of every $100 in revenue as profit
Strong operational efficiency at 24.3%
Earnings expanding 43.6% YoY
Reasonable price relative to book value
Revenue surging 91.6% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Premium valuation, high expectations priced in
Trading at 12.4x book value
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : DXCM
The strongest argument for DXCM centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 20.1% and operating margin at 24.3%. Revenue growth of 13.1% demonstrates continued momentum.
Bull Case : ITOC
The strongest argument for ITOC centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 91.6% demonstrates continued momentum.
Bear Case : DXCM
The primary concerns for DXCM are P/E Ratio, Price/Book.
Bear Case : ITOC
The primary concerns for ITOC are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
DXCM profiles as a mature stock while ITOC is a hypergrowth play — different risk/reward profiles.
ITOC carries more volatility with a beta of 2.77 — expect wider price swings.
ITOC is growing revenue faster at 91.6% — sustainability is the question.
DXCM generates stronger free cash flow (185M), providing more financial flexibility.
Bottom Line
DXCM scores higher overall (74/100 vs 33/100), backed by strong 20.1% margins and 13.1% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DexCom Inc
HEALTHCARE · MEDICAL DEVICES · USA
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
iTonic Holdings Ltd.
HEALTHCARE · MEDICAL DEVICES · USA
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?